Search Results - Frattini, M
- Showing 1 - 12 results of 12
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant by Molinari, F, Martin, V, Saletti, P, De Dosso, S, Spitale, A, Camponovo, A, Bordoni, A, Crippa, S, Mazzucchelli, L, Frattini, M
Published 2009Text -
9
-
10
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma by Mezzapelle, R, Miglio, U, Rena, O, Paganotti, A, Allegrini, S, Antona, J, Molinari, F, Frattini, M, Monga, G, Alabiso, O, Boldorini, R
Published 2013Text -
11
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients by Martin, V, Landi, L, Molinari, F, Fountzilas, G, Geva, R, Riva, A, Saletti, P, De Dosso, S, Spitale, A, Tejpar, S, Kalogeras, K T, Mazzucchelli, L, Frattini, M, Cappuzzo, F
Published 2013Text -
12
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients by Zlobec, I, Molinari, F, Kovac, M, Bihl, M P, Altermatt, H J, Diebold, J, Frick, H, Germer, M, Horcic, M, Montani, M, Singer, G, Yurtsever, H, Zettl, A, Terracciano, L, Mazzucchelli, L, Saletti, P, Frattini, M, Heinimann, K, Lugli, A
Published 2010Text